Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

C1510000

Chlorhexidine

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

1,1′-Hexamethylenebis[5-(4-chlorophenyl)biguanide]

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule linéaire :
[-(CH2)3NHC(=NH)NHC(=NH)NHC6H4Cl]2
Numéro CAS:
55-56-1
Poids moléculaire :
505.45
Numéro Beilstein :
2826432
Numéro MDL:
MFCD00009673
Code UNSPSC :
41116107
ID de substance PubChem :
329774893
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

chlorhexidine

Fabricant/nom de marque

EDQM

Technique(s)

HPLC: suitable
gas chromatography (GC): suitable

Pf

134-136 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Chaîne SMILES 

Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1

InChI

1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34)

Clé InChI

GHXZTYHSJHQHIJ-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Chlorhexidine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

PHR1222

Chlorhexidine acetate, Pharmaceutical Secondary Standard; Certified Reference Material

C1520000

Chlorhexidine diacetate, European Pharmacopoeia (EP) Reference Standard

C1540000

Chlorhexidine dihydrochloride, European Pharmacopoeia (EP) Reference Standard

PHR1294

Digluconate de chlorhexidine, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001545

Chlorhexidine for system suitability, European Pharmacopoeia (EP) Reference Standard

1111103

Chlorhexidine acetate, United States Pharmacopeia (USP) Reference Standard

PHR1459

Chlorhexidine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

1111001

Chlorhexidine, United States Pharmacopeia (USP) Reference Standard

1111012

Chlorhexidine System Suitability Mixture, United States Pharmacopeia (USP) Reference Standard

BP068

Chlorhexidine acetate, British Pharmacopoeia (BP) Reference Standard

Pictogrammes

CorrosionEnvironment
GHS05,GHS09

Mention d'avertissement

Danger

Mentions de danger

H318,H410

Classification des risques

Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

S Karki et al.
The Journal of hospital infection, 82(2), 71-84 (2012-08-15)
The topical use of chlorhexidine gluconate (CHG) is intended to reduce bacterial density on patients' skin. To assess the impact of body bath or skin cleansing with CHG-impregnated or CHG-saturated washcloths in preventing healthcare-associated infections and colonization. This systematic review
Richard Price et al.
BMJ (Clinical research ed.), 348, g2197-g2197 (2014-04-02)
To determine the effect on mortality of selective digestive decontamination, selective oropharyngeal decontamination, and topical oropharyngeal chlorhexidine in adult patients in general intensive care units and to compare these interventions with each other in a network meta-analysis. Systematic review, conventional
Afshin Haraji et al.
Journal of orofacial pain, 27(3), 256-262 (2013-07-25)
To assess the effects of intra-alveolar application of chlorhexidine gel on the incidence of alveolar osteitis (dry socket) and the severity of postsurgical pain. A total of 160 impacted mandibular third molars were extracted in 80 patients enrolled in this
Rengin Attin et al.
Australian orthodontic journal, 29(1), 52-57 (2013-06-22)
The aim of this prospective study was to evaluate the re-colonisation pattern of Streptococcus mutans (MS) in highlevel MS-colonised patients with fixed orthodontic appliances following 40% chlorhexidine varnish application prior to bracket placement. The subjects of this single-blinded clinical trial
Sissel Skovgaard et al.
The Journal of antimicrobial chemotherapy, 68(10), 2226-2233 (2013-06-07)
Chlorhexidine is used as a disinfectant to prevent surgical infections. Recently, studies have indicated that chlorhexidine usage has selected methicillin-resistant Staphylococcus aureus strains that are tolerant to chlorhexidine and that this may be related to the presence of the qacA/B-encoded
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique